FARINA, DEBORAH
 Distribuzione geografica
Continente #
NA - Nord America 2.222
EU - Europa 1.518
AS - Asia 1.333
SA - Sud America 201
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 5.300
Nazione #
US - Stati Uniti d'America 2.180
CN - Cina 523
SG - Singapore 422
UA - Ucraina 255
IE - Irlanda 254
GB - Regno Unito 199
TR - Turchia 179
SE - Svezia 176
BR - Brasile 169
DE - Germania 157
FR - Francia 154
IT - Italia 133
FI - Finlandia 78
IN - India 71
VN - Vietnam 64
RU - Federazione Russa 45
CA - Canada 25
CZ - Repubblica Ceca 17
MX - Messico 15
AR - Argentina 13
PL - Polonia 13
JP - Giappone 12
ZA - Sudafrica 11
IR - Iran 10
HK - Hong Kong 9
BD - Bangladesh 7
CH - Svizzera 7
ES - Italia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
EU - Europa 5
ID - Indonesia 5
LT - Lituania 5
EC - Ecuador 4
IQ - Iraq 4
KR - Corea 4
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
NL - Olanda 3
PK - Pakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
LB - Libano 2
NP - Nepal 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AT - Austria 1
CR - Costa Rica 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
MD - Moldavia 1
PH - Filippine 1
RO - Romania 1
SV - El Salvador 1
TW - Taiwan 1
Totale 5.300
Città #
Singapore 325
Chandler 323
Jacksonville 307
Dublin 253
Dallas 164
Beijing 160
Southend 152
Ashburn 130
Princeton 108
The Dalles 100
Izmir 92
Nanjing 89
Los Angeles 61
Dearborn 58
Wilmington 58
Munich 54
New York 52
Cambridge 49
Santa Clara 47
Altamura 37
Tongling 36
Nanchang 33
Ann Arbor 28
Ho Chi Minh City 26
Shenyang 21
São Paulo 20
Buffalo 17
Chieti 16
Hanoi 16
Montreal 16
Turku 15
Washington 15
Denver 14
Hebei 14
Jiaxing 14
Kunming 14
Tianjin 14
Boardman 13
Hangzhou 13
Helsinki 13
Woodbridge 13
Brno 12
Changsha 12
Grevenbroich 12
Redondo Beach 12
Tokyo 12
Warsaw 12
Jinan 11
Atlanta 10
Frankfurt am Main 10
Norwalk 10
Poplar 10
Brooklyn 9
Guangzhou 9
Hong Kong 9
Mexico City 9
Stockholm 9
Ardabil 8
Augusta 8
Houston 8
Johannesburg 8
Monmouth Junction 8
Orem 8
Phoenix 8
Boston 7
Camerino 7
Chennai 7
Chicago 7
Council Bluffs 7
San Mateo 7
Campobasso 6
Fribourg 6
Lanzhou 6
London 6
Rio de Janeiro 6
San Francisco 6
Brussels 5
Leawood 5
Manchester 5
Ningbo 5
Toronto 5
Brasília 4
Changchun 4
Curitiba 4
Hefei 4
Hải Dương 4
Montesilvano Marina 4
Nuremberg 4
Olomouc 4
Porto Alegre 4
Taizhou 4
Teramo 4
Amman 3
Amsterdam 3
Ankara 3
Annapolis 3
Belgrade 3
Belo Horizonte 3
Campinas 3
Da Nang 3
Totale 3.395
Nome #
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 144
Increasing age at disability milestones among MS patients in the MSBase Registry 138
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 136
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 131
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 131
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 127
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 124
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 120
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 119
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 118
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 118
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 118
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 117
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 115
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 114
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 113
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 113
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 113
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 109
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 108
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 106
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 106
JCV-Ab serostatus in MS patients treated with Natalizumab 105
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 104
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 103
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 102
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 100
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 98
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 96
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 96
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 96
Interferone beta: effetti collaterali 94
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. 94
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 93
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 93
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 92
Natalizumab-associated PML-IRIS: the Chieti experience. 91
Autologous HSCT for severe progressive Multiple Sclerosis in a multicenter trial: impact on disease activity and quality of life 89
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 89
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study 87
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 85
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 84
Interferone beta1b: bilancio su un gruppo di 30 pazienti 81
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 81
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 81
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis 80
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 80
Lymphomononuclear cells from multiple scerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. 79
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis 78
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 75
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 72
Long-term efficacy and tolerability of natalizumab treatment in multiple sclerosis patients: a multicentre experience in Italy 66
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 62
Totale 5.364
Categoria #
all - tutte 21.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 63 2 3 34 29 47 10
2021/2022213 1 4 6 49 6 2 6 19 12 3 31 74
2022/2023806 58 122 45 83 86 164 40 56 108 6 23 15
2023/2024397 34 18 25 6 29 164 72 3 1 7 2 36
2024/2025893 60 99 111 13 13 31 19 31 62 43 197 214
2025/20261.129 191 80 250 323 225 60 0 0 0 0 0 0
Totale 5.364